Biogen (BIIB) Treasury Shares (2009 - 2026)
Biogen (BIIB) posted quarterly Treasury Shares of $3.0 billion for Q2 2026, little changed year-over-year from $3.0 billion in Q2 2025, and little changed quarter-over-quarter from $3.0 billion in Q1 2026.
Biogen (BIIB) Treasury Shares (2009 - 2026) Analysis & Trends
Biogen's Treasury Shares history runs 18 years deep, the most recent figure standing at $3.0 billion for Q2 2026.
- In Q2 2026, Treasury Shares changed 0.0% year-over-year to $3.0 billion; the TTM figure through Jun 2026 stood at $3.0 billion (changed 0.0% YoY), while the FY2025 annual figure was $3.0 billion, changed 0.0% from the prior year.
- Treasury Shares for Q2 2026 stood at $3.0 billion, roughly flat from $3.0 billion in the prior quarter.
- The five-year high for Treasury Shares was $23.8 million in Q4 2022, with the low at -$23.8 million in Q1 2022.
- The 5-year median for Treasury Shares is -$23.8 million (2022), against an average of -$18.5 million.
- Peak annual rise in Treasury Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Biogen's Treasury Shares stood at $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
- Business Quant data shows BIIB's Treasury Shares at $3.0 billion in Q2 2026, $3.0 billion in Q1 2026, and $3.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 75.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 49.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 115.19 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | -23.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.80 Mn |
| Jun 30, 2026 | 2.98 Bn |
| Jun 30, 2026 | -23.80 Mn |
| Jun 30, 2026 | 2.98 Bn |
| Mar 31, 2026 | 2.98 Bn |
| Mar 31, 2026 | -23.80 Mn |
| Mar 31, 2026 | 2.98 Bn |
| Mar 31, 2026 | -23.80 Mn |
| Dec 31, 2025 | 2.98 Bn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | 2.98 Bn |
| Sep 30, 2025 | 2.98 Bn |
| Sep 30, 2025 | 2.98 Bn |
| Sep 30, 2025 | -23.80 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | 2.98 Bn |
| Jun 30, 2025 | 2.98 Bn |
| Jun 30, 2025 | -23.80 Mn |